These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 20457950)

  • 1. Human immunodeficiency virus-associated distal sensory polyneuropathy: still common after many successes.
    Kolson DL; González-Scarano F
    Arch Neurol; 2010 May; 67(5):534-5. PubMed ID: 20457950
    [No Abstract]   [Full Text] [Related]  

  • 2. Markers of immune activation and viral load in HIV-associated sensory neuropathy.
    Schifitto G; McDermott MP; McArthur JC; Marder K; Sacktor N; McClernon DR; Conant K; Cohen B; Epstein LG; Kieburtz K;
    Neurology; 2005 Mar; 64(5):842-8. PubMed ID: 15753420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of and risk factors for HIV-associated distal sensory polyneuropathy.
    Keswani SC; Hoke A
    Neurology; 2003 Jul; 61(2):279; author reply 279-80. PubMed ID: 12874429
    [No Abstract]   [Full Text] [Related]  

  • 4. Continued high prevalence and adverse clinical impact of human immunodeficiency virus-associated sensory neuropathy in the era of combination antiretroviral therapy: the CHARTER Study.
    Ellis RJ; Rosario D; Clifford DB; McArthur JC; Simpson D; Alexander T; Gelman BB; Vaida F; Collier A; Marra CM; Ances B; Atkinson JH; Dworkin RH; Morgello S; Grant I;
    Arch Neurol; 2010 May; 67(5):552-8. PubMed ID: 20457954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV neuropathy natural history cohort study: assessment measures and risk factors.
    Simpson DM; Kitch D; Evans SR; McArthur JC; Asmuth DM; Cohen B; Goodkin K; Gerschenson M; So Y; Marra CM; Diaz-Arrastia R; Shriver S; Millar L; Clifford DB;
    Neurology; 2006 Jun; 66(11):1679-87. PubMed ID: 16769940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distal sensory polyneuropathy in HIV-positive patients in the HAART era: an entity underestimated by clinical examination.
    Skopelitis EE; Kokotis PI; Kontos AN; Panayiotakopoulos GD; Konstantinou K; Kordossis T; Karandreas N
    Int J STD AIDS; 2006 Jul; 17(7):467-72. PubMed ID: 16820077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-associated distal sensory polyneuropathy in the era of highly active antiretroviral therapy: the Manhattan HIV Brain Bank.
    Morgello S; Estanislao L; Simpson D; Geraci A; DiRocco A; Gerits P; Ryan E; Yakoushina T; Khan S; Mahboob R; Naseer M; Dorfman D; Sharp V;
    Arch Neurol; 2004 Apr; 61(4):546-51. PubMed ID: 15096404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinal microangiopathy in human immunodeficiency virus infection is related to higher human immunodeficiency virus-1 load in plasma.
    Furrer H; Barloggio A; Egger M; Garweg JG;
    Ophthalmology; 2003 Feb; 110(2):432-6. PubMed ID: 12578793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of hepatitis C and hepatitis G virus co-infection on viral and cellular dynamics in patients infected with human immunodeficiency virus following interruption of highly active anti-retroviral therapy.
    Soriano-Sarabia N; Abad MA; Vallejo A; Gutiérrez S; Leal M
    Clin Microbiol Infect; 2006 Mar; 12(3):290-3. PubMed ID: 16451419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlates of epidermal nerve fiber densities in HIV-associated distal sensory polyneuropathy.
    Zhou L; Kitch DW; Evans SR; Hauer P; Raman S; Ebenezer GJ; Gerschenson M; Marra CM; Valcour V; Diaz-Arrastia R; Goodkin K; Millar L; Shriver S; Asmuth DM; Clifford DB; Simpson DM; McArthur JC;
    Neurology; 2007 Jun; 68(24):2113-9. PubMed ID: 17562831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antiretroviral therapy in 2004].
    Jablonowski H
    MMW Fortschr Med; 2004 Apr; 146 Spec No 1():46-8, 50-1. PubMed ID: 15373049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiviral treatment of human immunodeficiency virus infection: update for 2003.
    Postic B; Horvath JA; Talwani R
    J S C Med Assoc; 2003 Jun; 99(6):148-53. PubMed ID: 12886699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distal sensory polyneuropathy in the context of HIV/AIDS.
    Nicholas PK; Mauceri L; Slate Ciampa A; Corless IB; Raymond N; Barry DJ; Viamonte Ros A
    J Assoc Nurses AIDS Care; 2007; 18(4):32-40. PubMed ID: 17662922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Epidemiology of primary drug resistance in chronically HIV-infected patients in Nordrhein-Westfalen, Germany, 2001-2005].
    Oette M; Kaiser R; Däumer M; Fätkenheuer G; Rockstroh JK; Knechten H; Mitrenga D; Beerenwinkel N; Sagir A; Pfister H; Häussinger D
    Dtsch Med Wochenschr; 2007 May; 132(18):977-82. PubMed ID: 17457780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interruption of combination antiretroviral therapy and risk of clinical disease progression to AIDS or death.
    Holkmann Olsen C; Mocroft A; Kirk O; Vella S; Blaxhult A; Clumeck N; Fisher M; Katlama C; Phillips AN; Lundgren JD;
    HIV Med; 2007 Mar; 8(2):96-104. PubMed ID: 17352766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of HIV viral load, CD4 cell count and antiretroviral therapy on human papillomavirus prevalence in urine samples of HIV-infected men.
    Jong E; van Gorp EC; Mulder JW; Tol A; Smits PH
    Int J STD AIDS; 2009 Apr; 20(4):262-4. PubMed ID: 19304972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of HIV tropism on decreases in CD4 cell count, clinical progression, and subsequent response to a first antiretroviral therapy regimen.
    Waters L; Mandalia S; Randell P; Wildfire A; Gazzard B; Moyle G
    Clin Infect Dis; 2008 May; 46(10):1617-23. PubMed ID: 18419499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV type 2 demyelinating encephalomyelitis.
    Moulignier A; Lascoux C; Bourgarit A
    Clin Infect Dis; 2006 Jun; 42(11):e89-91. PubMed ID: 16652302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human T lymphotropic virus 1 and hepatitis C virus as risk factors for inflammatory dermatoses in HIV-positive patients.
    Bonamigo RR; Borges K; Rietjens J; Arenzon S; Blanco LF; Loureiro R
    Int J Dermatol; 2004 Aug; 43(8):568-70. PubMed ID: 15304178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.